https://puromycininhibitor.com..../higher-phrase-assoc
We, therefore, set out to construct and validate a prognostic nomogram applicable to DPM. The prognostic tool, which included age, ****, histological type, nuclear atypia, mitotic count, necrosis, and BAP1 immunohistochemistry, was developed using independent training and validation cohorts from 369 consecutive DPM patients. Risk stratification was used for assessment. To determine discriminatory power, the area under the receiver ope
Suka
Komentar
Membagikan
